{"id":4823,"date":"2010-12-16T16:00:51","date_gmt":"2010-12-16T21:00:51","guid":{"rendered":"http:\/\/insidesurgery.com\/?p=4823"},"modified":"2011-04-07T19:24:23","modified_gmt":"2011-04-07T23:24:23","slug":"fda-recommends-suspending-avastin-breast-cancer","status":"publish","type":"post","link":"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/","title":{"rendered":"FDA Recommends Suspending Use of Avastin for Breast Cancer"},"content":{"rendered":"


\nThe United States Food and Drug Administration is recommending that use of Avastin (bevacizumab) be suspended in the treatment of breast cancer because of too severe side effects with too little efficacy.<\/a> FDA officer Dr. Janet Woodcock comments.
\n<\/p>\n","protected":false},"excerpt":{"rendered":"

The United States Food and Drug Administration is recommending that use of Avastin (bevacizumab) be suspended in the treatment of breast cancer because of too severe side effects with too little efficacy. FDA officer Dr. Janet Woodcock comments.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[31],"tags":[3623,1527,1855,3624],"yoast_head":"\nFDA Recommends Suspending Use of Avastin for Breast Cancer - InsideSurgery Medical Information Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Recommends Suspending Use of Avastin for Breast Cancer - InsideSurgery Medical Information Blog\" \/>\n<meta property=\"og:description\" content=\"The United States Food and Drug Administration is recommending that use of Avastin (bevacizumab) be suspended in the treatment of breast cancer because of too severe side effects with too little efficacy. FDA officer Dr. Janet Woodcock comments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"InsideSurgery Medical Information Blog\" \/>\n<meta property=\"article:published_time\" content=\"2010-12-16T21:00:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2011-04-07T23:24:23+00:00\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/\",\"url\":\"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/\",\"name\":\"FDA Recommends Suspending Use of Avastin for Breast Cancer - InsideSurgery Medical Information Blog\",\"isPartOf\":{\"@id\":\"https:\/\/insidesurgery.com\/#website\"},\"datePublished\":\"2010-12-16T21:00:51+00:00\",\"dateModified\":\"2011-04-07T23:24:23+00:00\",\"author\":{\"@id\":\"https:\/\/insidesurgery.com\/#\/schema\/person\/80c1e5c67f8a2c348e38e202270e8594\"},\"breadcrumb\":{\"@id\":\"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/insidesurgery.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Recommends Suspending Use of Avastin for Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/insidesurgery.com\/#website\",\"url\":\"https:\/\/insidesurgery.com\/\",\"name\":\"InsideSurgery Medical Information Blog\",\"description\":\"Details of surgical procedures, pathophysiology, signs and symptoms, and treatment of medical diseases,medical and surgical eponyms, and surgeons and surgery in the news\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/insidesurgery.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/insidesurgery.com\/#\/schema\/person\/80c1e5c67f8a2c348e38e202270e8594\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/insidesurgery.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/41c3c845307fcd3eff88632d6ccaf656?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/41c3c845307fcd3eff88632d6ccaf656?s=96&d=mm&r=g\",\"caption\":\"Editor\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Recommends Suspending Use of Avastin for Breast Cancer - InsideSurgery Medical Information Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"FDA Recommends Suspending Use of Avastin for Breast Cancer - InsideSurgery Medical Information Blog","og_description":"The United States Food and Drug Administration is recommending that use of Avastin (bevacizumab) be suspended in the treatment of breast cancer because of too severe side effects with too little efficacy. FDA officer Dr. Janet Woodcock comments.","og_url":"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/","og_site_name":"InsideSurgery Medical Information Blog","article_published_time":"2010-12-16T21:00:51+00:00","article_modified_time":"2011-04-07T23:24:23+00:00","author":"Editor","twitter_misc":{"Written by":"Editor"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/","url":"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/","name":"FDA Recommends Suspending Use of Avastin for Breast Cancer - InsideSurgery Medical Information Blog","isPartOf":{"@id":"https:\/\/insidesurgery.com\/#website"},"datePublished":"2010-12-16T21:00:51+00:00","dateModified":"2011-04-07T23:24:23+00:00","author":{"@id":"https:\/\/insidesurgery.com\/#\/schema\/person\/80c1e5c67f8a2c348e38e202270e8594"},"breadcrumb":{"@id":"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/insidesurgery.com\/2010\/12\/fda-recommends-suspending-avastin-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/insidesurgery.com\/"},{"@type":"ListItem","position":2,"name":"FDA Recommends Suspending Use of Avastin for Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/insidesurgery.com\/#website","url":"https:\/\/insidesurgery.com\/","name":"InsideSurgery Medical Information Blog","description":"Details of surgical procedures, pathophysiology, signs and symptoms, and treatment of medical diseases,medical and surgical eponyms, and surgeons and surgery in the news","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/insidesurgery.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/insidesurgery.com\/#\/schema\/person\/80c1e5c67f8a2c348e38e202270e8594","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/insidesurgery.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/41c3c845307fcd3eff88632d6ccaf656?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41c3c845307fcd3eff88632d6ccaf656?s=96&d=mm&r=g","caption":"Editor"}}]}},"_links":{"self":[{"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/posts\/4823"}],"collection":[{"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/comments?post=4823"}],"version-history":[{"count":0,"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/posts\/4823\/revisions"}],"wp:attachment":[{"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/media?parent=4823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/categories?post=4823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insidesurgery.com\/wp-json\/wp\/v2\/tags?post=4823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}